- ... agents for the treatment of TNBC. Poly (ADP-ribose) polymerase (PARP) inhibitor agents The PARP inhibitors are ... Winer EP, Ford JM, et al.: Poly(ADP-Ribose) polymerase inhibition: "targeted" therapy for triple-negative breast ...
- ... in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by killing cancer ...
- ... in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by killing cancer ...
- ... in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by stopping or ...
- ... in a class of medications called poly (ADP-ribose) polymerase (PARP) inhibitors. It works by killing cancer ...
- ... 166 ] Furthermore, novel agents such as poly (ADP-ribose) polymerase (PARP) inhibitors may be used in the ... and TIRAPR , which codes for a poly (ADP-ribose) polymerase, molecules that may be important in BRCA1/ ...
- ... factor$” adj2 inhibitor$).ti,ab. 71 “Poly(ADP-ribose) Polymerases”/ 72 ((“poly ADP-ribose polymerase” or polymerase) adj2 inhibitor$).ti,ab. 73 ( ... adenine dinucleotide adenosine diphosphate ribosyltransferase/ 70 ((“poly ADP-ribose polymerase” or polymerase) adj2 inhibitor$).ti,ab. 71 ( ...
- ... cancer that has recurred (come back). Poly (ADP-ribose) polymerase inhibitors (PARP inhibitors) are targeted therapy drugs ... Chemotherapy and targeted therapy with a poly (ADP-ribose) polymerase (PARP) inhibitor . Chemotherapy followed by surgery (possibly ...
- ... of thymidine to thymine and 2-deoxy-D-ribose 1-phosphate [ Brown & Bicknell 1998 ]. The forward reaction ( ... H]-thymidine. TP may be angiogenic indirectly because ribose liberated from the degradation of thymidine may stimulate ...
- ... sugar found in most carbohydrates) to another sugar, ribose-5-phosphate. Ribose-5-phosphate is an important component of nucleotides, ...
21 results